(Q37770215)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Castleman's disease--a two compartment model of HHV8 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Nadia Talat

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

6 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

533-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603649%20AND%20SRC:MED&resulttype=core&format=json

Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Localized mediastinal lymphnode hyperplasia resembling thymoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

HIV-associated multicentric Castleman's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Multicentric giant lymph node hyperplasia. A report of seven cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

HIV-associated multicentric Castleman disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Castleman disease: an update on classification and the spectrum of associated lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Probably neoplastic proliferation of lymphoid tissue (follicular lympho-reticuloma). Reports of four cases with a survey of literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Immunoglobulin and T-cell receptor gene rearrangement in Castleman's disease: molecular genetic analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Lymph Nodes Involved by Multicentric Castleman Disease Among HIV-positive Individuals are Often Involved by Kaposi Sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Relationship between the Quantity of Kaposi Sarcoma–Associated Herpesvirus (KSHV) in Peripheral Blood and Effusion Fluid Samples and KSHV‐Associated Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Primary effusion lymphoma in HIV-infected patients with multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Kaposi's sarcoma-associated herpesvirus infection in the lung in multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Expression of vascular endothelial growth factor in lymphomas and Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Interleukin 6: from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

B cell development pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Properties of the mantle cell and mantle cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

The human marginal zone B cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

The first reported case and management of multicentric Castleman??s disease associated with Kaposi??s sarcoma in an HIV-2-infected patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Functions of Tat: the versatile protein of human immunodeficiency virus type 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Imaging findings of Castleman disease of the abdomen and pelvis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

CT features of Castleman disease of the abdomen and pelvis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Focal Castleman disease of the lung: MRI findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Radiological presentations of Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Unicentric and multicentric Castleman's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Hodgkin's disease presenting with the histological features of Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Hodgkin's and Castleman's disease in a patient with systemic mastocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Interfollicular Hodgkin's lymphoma and Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Plasma cell variant of Castleman's disease occurring concurrently with Hodgkin's disease in the neck

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Plasmacytoid dendritic cells: physiologic roles and pathologic states.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Paraneoplastic pemphigus in association with Castleman's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

18F-FDG PET/CT in the evaluation of POEMS syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Absence of human herpesvirus-8 in glomeruloid haemangiomas associated with POEMS syndrome and Castleman's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Sarcoma arising in hyaline-vascular castleman disease of skin and subcutis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

HHV-8 is not associated with follicular dendritic cell tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Enhancing mediastinal mass at MR: Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Solitary intracranial Castleman's disease, plasma cell variant: a case report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Multicentric Giant Lymph Node Hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Treatment of HIV-associated multicentric Castleman's disease with oral etoposide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Rituximab therapy for HIV-associated Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

CD19: a promising B cell target for rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Antiangiogenesis in haematological malignancies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.103

31 March 2020

1 reference

12 December 2020

Interleukin-6 gene expression in Castleman's disease

1 reference

12 December 2020

[Kaposi's disease and HHV8: a new model of virus-induced tumorigenesis]

1 reference

12 December 2020

Lymphnodal hamartoma versus thymic choristoma of pulmonary hilum

1 reference

12 December 2020

Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.

1 reference

12 December 2020

HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma

1 reference

12 December 2020

Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease

1 reference

12 December 2020

Multicentric Castleman's disease in HIV infection: a systematic review of the literature

1 reference

12 December 2020

1 reference

12 December 2020

Angiofollicular mediastinal lymph-node hyperplasia resembling thymoma

1 reference

12 December 2020

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

1 reference

12 December 2020

Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

1 reference

12 December 2020

PET/CT findings in a multicentric form of Castleman's disease.

1 reference

12 December 2020

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

1 reference

12 December 2020

Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.

1 reference

12 December 2020

Human herpesvirus 8 encodes a homolog of interleukin-6.

1 reference

12 December 2020

Rhesus monkey rhadinovirus: a model for the study of KSHV.

1 reference

12 December 2020

Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases

1 reference

12 December 2020

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease

1 reference

12 December 2020

Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.

1 reference

12 December 2020

Cytomorphology of hyaline-vascular Castleman's disease: A diagnostic challenge

1 reference

12 December 2020